Goldman Sachs Group »

Capstone Therapeutics Corporat shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Capstone Therapeutics Corporat (CAPS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Capstone Therapeutics Corporat

Tip: Access up to 7 years of quarterly data

All positions including Capstone Therapeutics Corporat held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capstone Therapeutics Corporat by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.0k 16k 0.25

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Capstone Therapeutics Corporat

Geode Capital Management
Jane Street
Intl Fcstone
Hrt Financial
Goldman Sachs Group
Northern Trust
Ground Swell Capital
Barclays
KERR FINANCIAL PLANNING Corp
Citigroup
Morgan Stanley

View all funds holding Capstone Therapeutics Corporat